The Top Robinhood Options Trade Now Is a 130% Profit Play

The race to a vaccine has investors stalking the biotech companies in the mix for any clues of who will win. But the biggest profit opportunities in this sector don't have anything to do with the vaccine.

You see, biotechs are often small companies that can explode in share price if they secure FDA approval for a profitable drug. We're going to show you an opportunity to play one of the most promising stocks today with the best options trade on Robinhood right now. We think traders of all skill levels should have the opportunity to make money trading options, which is why we uncover options trades anyone can do on popular and free platforms like Robinhood and WeBull.

No doubt, COVID-19 is dominating the news and even our lives. That's why the Trump administration launched "Operation Warp Speed" to get this pandemic under control so we can fully open the economy, get back to school, and finally return to normal. The U.S. government is investing billions of dollars in biotech companies to develop a vaccine as quickly as possible, but nobody knows which one will be first and which one will work best.

You might think that you can hedge your bets by buying a little bit of every company that is a part of this effort. Unfortunately, you can't serve up superior returns with a blended portfolio, much like an ETF. What you have to do is own the best of the best biotech stocks so you actually get a portfolio pop when that vaccine is finally released.

However, this singular focus on the coronavirus is almost making phase 3 trials for other, non-related drugs and equipment invisible. Traders are overlooking these other winners when vaccines are much shinier objects.

Options 101: Trading options is the perfect way to cash in on a volatile market, and you can learn from top expert Tom Gentile today. Click here to get Options 101: The Easiest Options Guide You'll Ever Read for free.

But traders like you who are seeking out expert research aren't making this mistake.

Money Morning Quantitative Trading Specialist Chris Johnson has been looking into this and has come up with a company that is flying under the radar right now despite its clear upward trajectory. This company isn't developing a vaccine for anything but has explosive profit potential just the same.

Rather, it is a provider of diagnostic equipment and products that operate on the genome level. That means it creates products that can peer down into the patient's DNA to better assess their condition and point to the correct therapies to treat it. These include treatments for thyroid cancer, lung cancer screening, and even a COVID-19 test kit with a partner firm.

The stock has been outperforming the market over the past month, and it finally was able to clear the top of its year-and-a-half trading range. This happened last week following its Q2 earnings report.

But Chris' research shows this stock isn't slowing down anytime soon, and by using options, you can turn this company's rise into 130% gains by the end of the year.

And remember, this is an options trade easy enough to do on popular platforms like Robinhood.

We'll show you exactly how to do it...

The Best Options Trade on Robinhood Right Now

[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]

Chris' stock is Veracyte Inc. (NASDAQ: VCYT). Veracyte is in the hottest industry right now but is not directly caught in the fray to develop a COVID-19 vaccine. However, it is excelling in its corner of the biotech/healthcare segment and is being overlooked by the "too fast" money crowd. That's why it's set up nicely to soar, once the Street figures out what they've been missing.

That's why Chris thinks it can rally to $46 a share by year-end. That could provide a healthy profit for someone holding the stock, but as readers know, we like to do even more.

Not only do options give you the chance to control hundreds of shares of the stock at once, but they give you the opportunity for outsized gains if the stock moves the way Chris forecasts.

He likes the VRCT March 19 2021 $35 call. It traded near $6 this week, but since it is a bit thinly traded this far from expiration, be sure to use a limit order, which specifies the maximum price you're willing to pay.

Should Veracyte stock reach $46 in December, the option would be worth about 130% more than today's price. That would more than double your money on a very promising biotech.

Millennial Millionaire's One-of-a-Kind Trading System

It's been generating money hand over fist since the recession of 2008... and now, he's finally sharing the secret!

Investors in today's economic climate need every advantage they can get, and I don't think I've ever seen a strategy more powerful than this.

Click here for the full story and the next three plays he has his eye on.

Follow Money Morning onFacebook and Twitter.